111 related articles for article (PubMed ID: 17394012)
21. [Therapeutic choices for rectal cancer].
Ligue Nationale contre le Cancer
Gastroenterol Clin Biol; 2006 Jan; 30(1):59-69. PubMed ID: 16514383
[No Abstract] [Full Text] [Related]
22. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
23. Rectal cancer: the role of radiotherapy.
Lidder PG; Hosie KB
Dig Surg; 2005; 22(1-2):41-8; discussion 49. PubMed ID: 15838170
[TBL] [Abstract][Full Text] [Related]
24. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
Guckenberger M; Saur G; Wehner D; Thalheimer A; Kim M; Germer CT; Flentje M
Radiother Oncol; 2013 Aug; 108(2):326-30. PubMed ID: 24021342
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy.
Wang L; Zhai ZW; Ji DB; Li ZW; Gu J
Int J Colorectal Dis; 2015 Jun; 30(6):753-60. PubMed ID: 25935450
[TBL] [Abstract][Full Text] [Related]
26. [Quality for the data basis of evidence-based medicine: rectal cancer and preoperative 5 x 5 irradiation].
Kornmann M; Henne-Bruns D
Zentralbl Chir; 2008 Feb; 133(1):20-4. PubMed ID: 18278697
[TBL] [Abstract][Full Text] [Related]
27. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
[TBL] [Abstract][Full Text] [Related]
28. [Radiotherapy of rectal cancer].
Ciernik IF
Praxis (Bern 1994); 2004 Sep; 93(36):1441-6. PubMed ID: 15487856
[TBL] [Abstract][Full Text] [Related]
29. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
[TBL] [Abstract][Full Text] [Related]
32. Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma.
Vironen J; Juhola M; Kairaluoma M; Jantunen I; Kellokumpu I
Int J Colorectal Dis; 2005 Sep; 20(5):440-5. PubMed ID: 15856263
[TBL] [Abstract][Full Text] [Related]
33. Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation.
Caricato M; Borzomati D; Ausania F; Tonini G; Rabitti C; Valeri S; Trodella L; Ripetti V; Coppola R
Surg Endosc; 2006 Aug; 20(8):1203-7. PubMed ID: 16703429
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy in rectal cancer: is it time for change? A qualitative analysis of the national questionnaire survey of members of ACPGBI on preliminary CRO7 results.
Srinivasaiah N; Monson JR
Colorectal Dis; 2008 Nov; 10(9):873-8. PubMed ID: 18325044
[TBL] [Abstract][Full Text] [Related]
35. [Rectal carcinoma--oncologically adequate resection].
Simon D
Praxis (Bern 1994); 2001 Apr; 90(14):575-80. PubMed ID: 11320884
[TBL] [Abstract][Full Text] [Related]
36. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
37. Integration of novel agents into combined-modality treatment for rectal cancer patients.
Rödel C; Sauer R
Strahlenther Onkol; 2007 May; 183(5):227-35. PubMed ID: 17497093
[TBL] [Abstract][Full Text] [Related]
38. [Advanced rectal cancer: attitudes of French surgeons].
Arnaud S; Houvenaeghel G; Julian-Reynier C; Moutardier V; Delpero JR; Moatti JP
Ann Chir; 2003 Jun; 128(5):293-300; discussion 301-2. PubMed ID: 12878064
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
[TBL] [Abstract][Full Text] [Related]
40. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
